Nenad Sarapa

Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase

Börje Darpö, Charles Benson, Corina Dota et al. · Clinical Pharmacology & Therapeutics · 2015 · 176 citations · Full text

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Raffit Hassan, George R. Blumenschein, Kathleen N. Moore et al. · Journal of Clinical Oncology · 2020 · 164 citations · Full text

Evaluation of Tumor-Size Response Metrics to Predict Overall Survival in Western and Chinese Patients With First-Line Metastatic Colorectal Cancer

Laurent Claret, Manish Gupta, Kelong Han et al. · Journal of Clinical Oncology · 2013 · 140 citations

Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods

Nenad Sarapa, Joel Morganroth, Jean‐Philippe Couderc et al. · Annals of Noninvasive Electrocardiology · 2004 · 95 citations · Full text

Pharmacotherapy, Manual Digipad, Medical Instrumentation +19

The Application of Accelerator Mass Spectrometry to Absolute Bioavailability Studies in Humans: Simultaneous Administration of an Intravenous Microdose of ¹⁴C‐Nelfinavir Mesylate Solution and Oral Nelfinavir to Healthy Volunteers

Nenad Sarapa, Poe‐Hirr Hsyu, Graham Lappin et al. · The Journal of Clinical Pharmacology · 2005 · 67 citations

Simultaneous Administration, Pharmaceutical Science, New Drug Candidates +17